Klaus joined OrbiMed in 2007 as a Venture Partner and is focused on venture investments in the therapeutic space. Since joining OrbiMed, he has served or currently serves on the boards of numerous public and private OrbiMed portfolio companies. Previously, Klaus was the Chief Executive Officer of Schwarz Pharma Inc. with responsibility for the U.S. and Asia businesses culminating in the ultimate sale of the Schwarz Group. For seven years he was a Director of PhRMA. He received his medical degree and his doctorate (Ph.D.) from the University of Heidelberg and earned his M.B.A. at INSEAD in France.
- Over 30 years of drug development, commercial, licensing/M&A, and general management experience in the life science sector
- Over 15 years “getting his hands dirty” in helping venture-backed companies grow
- Loves to be in the mountains for hiking, biking, and skiing